Stonebridge Financial Group (Pennsylvania)’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-242
Closed -$27.4K 976
2025
Q1
$27.4K Buy
242
+2
+0.8% +$214 ﹤0.01% 461
2024
Q4
$25.4K Buy
+240
New +$25.8K ﹤0.01% 467

Other funds holding ZBH

Stonebridge Financial Group (Pennsylvania)'s ZBH Position: Q2 2025 in Review

Stonebridge Financial Group (Pennsylvania) sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 242 shares — an estimated $27.4K sold.

Stonebridge Financial Group (Pennsylvania) first reported a position in ZBH in Q4 2024 and held it in 2 quarters. The position peaked at $27.4K in Q1 2025. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • Stonebridge Financial Group (Pennsylvania) reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • Stonebridge Financial Group (Pennsylvania) sold 242 Zimmer Biomet shares in Q2 2025, an estimated $27.4K.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in Zimmer Biomet in Q4 2024 and held it in 2 quarters.
  • Stonebridge Financial Group (Pennsylvania)'s Zimmer Biomet position peaked at $27.4K in Q1 2025.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2025, filed 24 Jul 2025.